Page Tools:

HIV Essentials 2017

Author(s): Paul E. Sax, MD, Clinical Director, Division of Infectious Diseases and HIV Program, Brigham and Women's Hospital, Boston, Massachusetts, Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts
Calvin J. Cohen, MD, MS, Clinical Director, Division of Infectious Diseases and HIV Program, Brigham and Women's Hospital, Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts
Daniel R. Kuritzkes, MD, Professor of Medicine and Director of AIDS Research, Brigham and Women's Hospital, Boston, Massachusetts, Principal Investigator and Chair, AIDS Clinical Trials Group Executive Committee, Associate Editor, Journal of Infectious Diseases
Details:
  • ISBN-13: 9781284124705
  • Paperback    300 pages      © 2017
Price: $25.95 US List
Add to Cart

The world's leading experts provide all the 'essentials' needed to manage HIV patients in the office, on the ward, and in the ICU.
 
Completely revised and updated, HIV Essentials 2017 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management, and prevention of HIV infection and its complications. Topics include: opportunistic infections and other HIV complications, treatment of HIV and pregnancy, antiretroviral drug summaries, post-exposure prophylaxis, as well as commercially available dosage forms for all ARVs.

Paul E. Sax, MD-Clinical Director, Division of Infectious Diseases and HIV Program, Brigham and Women's Hospital, Boston, Massachusetts, Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts

Paul E. Sax, MD is Clinical Director of the Division of Infectious Diseases and the HIV Program at Brigham and Women's Hospital (BWH) in Boston.  He has been on the faculty at Harvard Medical School since 1992, where he is currently an Associate Professor of Medicine.  Dr. Sax received his MD from Harvard Medical School in 1987, served his residency in Internal Medicine at BWH, and continued his postdoctoral education with a fellowship in the Infectious Disease Unit of Masschusetts General Hospital.  Dr. Sax is Editor-in-Chief of AIDS Clinical Care, is on the peer review board of the HIV/AIDS Section of UpToDate, and is the HIV disease section editor for Infectious Diseases Special Edition and Antibiotic Essentials.  He is also on the core faculty of the International AIDS Society - USA and the New England AIDS Education and Training Center.  He is actively involved in patient care, teaching and HIV research, and his main research interests include clinical trials of antiretroviral therapies, cost effectiveness of management strategies for HIV, toxicity of antiretroviral treatment, and identification, treatment and outcome of primary HIV infection.  He is presently the principal investigator at the BWH AIDS Clinical Trials Unit and a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group.  Dr. Sax lectures nationally and internationally on HIV therapy and has contributed many HIV-related publications to the medical literature.  He was awarded the Edward H. Kass Award in Clinical Excellence in 1993, the Harvard-Longwood Infectious Disease Fellowship Award in Clinical Teaching in 1997, and a Distinguished Faculty Resident Mentoring Award in 2003.

Calvin J. Cohen, MD, MS-Clinical Director, Division of Infectious Diseases and HIV Program, Brigham and Women's Hospital, Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts

Daniel R. Kuritzkes, MD-Professor of Medicine and Director of AIDS Research, Brigham and Women's Hospital, Boston, Massachusetts, Principal Investigator and Chair, AIDS Clinical Trials Group Executive Committee, Associate Editor, Journal of Infectious Diseases

Daniel R. Kuritzkes, MD, received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University in 1978, and his MD from Harvard Medical School in 1983. He completed his clinical and research training in internal medicine and infectious disease at Massachusetts General Hospital, and was a visiting scientist at the Whitehead Institute for Biomedical Research before joining the faculty at the University of Colorado Health Sciences Center in 1990. Dr. Kuritzkes returned to Harvard Medical School in 2002, where he is currently Professor of Medicine and Director of AIDS Research, Brigham & Women’s Hospital. Dr. Kuritzkes has written widely on antiretroviral therapy and on the problem of drug resistance in HIV-1 infection. He currently serves as Principal Investigator and Chair of the AIDS Clinical Trials Group Executive Committee. Dr. Kuritzkes also is an Associate Editor of the Journal of Infectious Diseases. His research interests focus on antiretroviral therapy and drug resistance.